SJG 136
中文名稱 | SJG 136 |
---|---|
中文同義詞 | (11AS,11'AS)-8,8'-[1,3-丙二基雙(氧基)]雙[1,2,3,11A-四氫-7-甲氧基-2-亞甲基-5H-吡咯并[2,1-C] [1,4]苯并二氮雜-5-酮];(11A S,11A'S)-8,8'-(丙烷-1,3-二基雙(氧))雙(7-甲氧基-2-亞甲基-2,3-二氫-1H-苯并[E]吡咯[1,2-A][1,4]二氮雜卓-5(11AH)-酮);化合物 T16890;(11A S,11A'S)-8,8'-(丙烷-1,3-二基雙(氧))雙(7-甲氧基-2-亞甲基-2,3-二氫-1H-苯并[E]吡咯[1,2-A][1,4]二氮雜卓-5(11AH)-酮);化合物 SJG-136 |
英文名稱 | BN-2629 |
英文同義詞 | BN-2629;NSC 694501;SJG 136;UP 2001;SG2000;SP-2001;(11aS,11'aS)-8,8'-[1,3-Propanediylbis(oxy)]bis[1,2,3,11a-tetrahydro-7-methoxy-2-methylene-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one;CS-1384 |
CAS號(hào) | 232931-57-6 |
分子式 | C31H32N4O6 |
分子量 | 556.61 |
EINECS號(hào) | |
相關(guān)類別 | |
Mol文件 | 232931-57-6.mol |
結(jié)構(gòu)式 |
SJG 136 性質(zhì)
沸點(diǎn) | 805.5±65.0 °C(Predicted) |
---|---|
密度 | 1.36±0.1 g/cm3(Predicted) |
儲(chǔ)存條件 | Sealed in dry,Room Temperature |
溶解度 | 二甲基亞砜:≥100mg/mL(179.66mM) |
酸度系數(shù)(pKa) | 3.88±0.20(Predicted) |
形態(tài) | 固體 |
顏色 | 米白色至黃色 |
XL50: 45 nM (pBR322 DNA)
SJG-136 (dimer 5) is a DNA cross-linking agent, with an XL 50 (concentration of agent required for 50% cross-linking of pBR322 DNA) of 45 nM for pBR322 DNA. SJG-136 is cytotoxic to ovarian cell lines, such as A2780 (IC 50 , 22.5 pM), A2780cisR (IC 50 , 24 pM), CH1 (IC 50 , 0.12 nM), CH1cisR (IC 50 , 0.6 nM), and SKOV-3 (IC 50 , 9.1 nM). SJG-136 (SG2000) also reduces the viability of a panel of canine cancer cells, with GI 50 values ranging from 0.33 - >100 nM after a 1 h exposure, and <0.03 - 17.33 nM following continuous exposure.
SJG-136 shows more potent antitumor effect against CMeC-1 tumour at 0.30 mg/kg than 0.15 mg/kg either as a single dose or administered once a week for three weeks via dosed intravenously in mice. SJG-136-induced H2AX phosphorylation shows good correspondence, but less sensitivity, than measurement of foci.
安全信息
更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
---|---|---|---|---|---|
2024/11/08 | HY-14573 | SJG 136 SJG-136 | 232931-57-6 | 1 mg | 2800元 |
2024/11/08 | HY-14573 | SJG 136 SJG-136 | 232931-57-6 | 5mg | 4900元 |